Skip to content

e-Natureza Project - Affective Validation of Nature Images for Hospital Use

e-Natureza: Affective Validation of Nature Images as a Complementary Resource for Promoting Well-being in Hospital Environment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03518255
Acronym
E-natureza
Enrollment
164
Registered
2018-05-08
Start date
2018-08-22
Completion date
2021-02-08
Last updated
2021-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Nursing Care, Complementary therapies, Oncological Nursing, Photography

Brief summary

Randomized clinical trial about the evaluation of the use of nature photographs in the positive and negative affects of oncological patients.

Detailed description

In recent decades there has been growing interest from researchers in understanding how the adoption of natural elements in daily life, even in hospitals, can characterize restorative environments and reflect in better health for patients. Contact with nature can be done indirectly through photographs. This clinical trial aims to verify the therapeutic potential of the nature images, previously validated in another part of this study, in the care of cancer patients undergoing chemotherapy. Anchored on the assumptions of the theory of Biophilia, and the environmental theory of Florence Nightingale our study hypothesis is that this intervention promotes well-being and promote more positive mood states, and reduce symptoms resulting from the treatment during chemotherapy session.

Interventions

After signing the Informed Consent Form, the participants will respond to a demographic questionnaire to characterize the sample and then they will watch nature videos. After that, will be applied a scale questionnaire about the physical and psychological symptoms of chemotherapy in the positive and negative mood of that patient.

Sponsors

Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
Butantan Institute
CollaboratorOTHER_GOV
Hospital Israelita Albert Einstein
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

This study has no masking.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Voluntary participation; * Signed in the Informed Consent Form; * Who are undergoing chemotherapy treatment; * Patients need to be on the first chemotherapy session, independently of oncological disease; * Patients with clinical conditions and preserved communication function, in other words, lucid patients.

Exclusion criteria

* Blind patients; * Patients without the capacity for judgment, in other words, with dementia; * Patients who have their clinical condition aggravated during the chemotherapy session.

Design outcomes

Primary

MeasureTime frameDescription
Positive and Negative Affect Schedule (PANAS)Change from Baseline positive and negative affects at immediate post intervention, through study completion, an average of 1 yearThe questionnaire aims to verify the positive and negative affects of participants in oncologic treatment before and after their first chemotherapy session, in order to verify if after the intervention, the negative affects decrease and the positive ones increase. Each questionnaire will be analyzed individually.

Secondary

MeasureTime frameDescription
Edmonton Symptom Assessment Scale (ESAS-Br)Change from Baseline Edmonton Symptoms at immediate post intervention, through study completion, an average of 1 yearThis tool is designed to assist in the assessment of nine symptoms common in cancer patients: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, wellbeing and shortness of breath, (there is also a line labelled Other Problem). The severity at the time of assessment of each symptom is rated from 0 to 10 on a numerical scale, 0 meaning that the symptom is absent and 10 that it is of the worst possible severity. It does not have final classification scores. It measures the frequency and intensity of symptoms presented at the time of its application.

Other

MeasureTime frameDescription
The Connectedness to Nature ScaleSingle baseline measurementThe Nature Connection Scale is used to verify the affective aspect of the person-environment relationship. It is composed of 14 items, which are answered in a scale of 5 points, ranging from 1 (I totally disagree) to 5 (I totally agree). The higher the score, the greater the individual's connection with nature.
Nature Relatedness QuestionnaireSingle baseline measurementThe 21-item Nature Relatedness Scale (NR) assesses subjective connectedness with the natural environment. Participants respond to statements using a 5-point Likert scale (1 = strongly disagree, 5 = strongly agree) and items are averaged with higher scores indicating stronger connectedness.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026